Literature DB >> 11708885

Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.

J Unsinger1, A Kröger, H Hauser, D Wirth.   

Abstract

Regulated transgene expression is increasingly used in research but is also needed for certain therapies. Regulatory systems are usually composed of two expression units, one bearing the gene of interest under control of a regulatable promoter and the other, a constitutively expressed transactivator that modulates the activity of the regulatable promoter. Because the cotransfer of two independent elements is not efficient in primary cells, single transduction step vectors conferring regulatable gene expression cassettes would be helpful. We have developed retroviral vectors containing an autoregulatory bidirectional expression cassette that encodes all components necessary for regulated expression of a gene of interest. The influence of the orientation of the reporter gene with respect to the viral long terminal repeat (LTR) and the effect of transcriptionally inactive LTRs were investigated using mouse leukemia virus (MLV) and self-inactivating (SIN)-based retroviral vectors. Strict regulation was observed when the reporter was inserted in antisense orientation with respect to the LTR, whereas a sense arrangement of the reporter resulted in a loss of regulation capacity. Expression and regulation of the antisense-orientated reporter gene were homogenous in infected cell pools and investigated cell clones. Long-term observations of infected cells over a period of 30 passages revealed stable expression and regulation. These autoregulated, bidirectional retroviral vectors combine the advantages of single-step transduction with strict regulation of the gene of interest in the infected target cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708885     DOI: 10.1006/mthe.2001.0480

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  8 in total

1.  Green fluorescent protein-tagged retroviral envelope protein for analysis of virus-cell interactions.

Authors:  Dirk Spitzer; Kurt E J Dittmar; Manfred Rohde; Hansjörg Hauser; Dagmar Wirth
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization.

Authors:  Tobias May; Hansjörg Hauser; Dagmar Wirth
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

3.  Retroviral vectors containing Tet-controlled bidirectional transcription units for simultaneous regulation of two gene activities.

Authors:  Rainer Loew; Elisa Vigna; Dirk Lindemann; Luigi Naldini; Herman Bujard
Journal:  J Mol Genet Med       Date:  2006-07-17

4.  Current status of transcriptional regulation systems.

Authors:  Tobias May; Hansjörg Hauser; Dagmar Wirth
Journal:  Cytotechnology       Date:  2006-05-20       Impact factor: 2.058

5.  Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter.

Authors:  David Markusic; Ronald Oude-Elferink; Atze T Das; Ben Berkhout; Jurgen Seppen
Journal:  Nucleic Acids Res       Date:  2005-04-04       Impact factor: 16.971

6.  Synthetic rewiring and boosting type I interferon responses for visualization and counteracting viral infections.

Authors:  Natascha Gödecke; Jan Riedel; Sabrina Herrmann; Sara Behme; Ulfert Rand; Tobias Kubsch; Luka Cicin-Sain; Hansjörg Hauser; Mario Köster; Dagmar Wirth
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

7.  Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivator.

Authors:  Niels Heinz; Katharina Hennig; Rainer Loew
Journal:  BMC Biotechnol       Date:  2013-01-22       Impact factor: 2.563

8.  Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo.

Authors:  Beihui Liu; Julian F Paton; Sergey Kasparov
Journal:  BMC Biotechnol       Date:  2008-05-16       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.